|
1
|
Wagner AD, Grothe W, Haerting J, Kleber G,
Grothey A and Fleig WE: Chemotherapy in advanced gastric cancer: A
systematic review and meta-analysis based on aggregate data. J Clin
Oncol. 24:2903–2909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parrales A and Iwakuma T: Targeting
oncogenic mutant p53 for cancer therapy. Front Oncol.
21:2882015.
|
|
3
|
Kamada R, Toguchi Y, Nomura T, Imagawa T
and Sakaguchi K: Tetramer formation of tumor suppressor protein
p53: Structure, function, and applications. Biopolymers.
106:598–612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krig SR, Miller JK, Frietze S, Beckett LA,
Neve RM, Farnham PJ, Yaswen PI and Sweeney CA: ZNF217, a candidate
breast cancer oncogene amplified at 20q13, regulates expression of
the ErbB3 receptor tyrosine kinase in breast cancer cells.
Oncogene. 29:5500–5510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao Z, Wang D, Zhu C, Shao H, Sun C, Qiu
H, Xue L, Xu J, Guo M and Li W: Aberrant alternative splicing of
human ZNF gene ZNF268 in human hematological malignancy. Oncol Rep.
20:1243–1248. 2008.PubMed/NCBI
|
|
6
|
Deng MJ, Li XB, Peng H and Zhang JW:
Identification of the trans-activation domain and the nuclear
location signals of human zinc finger protein HZF1 (ZNF16). Mol
Biotechnol. 44:83–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng H, Begg GE, Harper SL, Friedman JR,
Speicher DW and Rauscher FJ II: Biochemical analysis of the
Kruppel-associated Box (KRAB) transcriptional repression domain. J
Biol Chem. 275:18000–18010. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Liang Q, Wen YQ, Chen LL, Wang LT,
Liu YL, Luo CQ, Liang HZ, Li MT and Li Z: Comparative proteomics
analysis of human osteosarcomas and benign tumor of bone. Cancer
Genet Cytogenet. 198:97–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bar-Shira A, Pinthus JH, Rozovsky U,
Goldstein M, Sellers WR, Yaron Y, Eshhar Z and Orr-Urtreger A:
Multiple genes in human 20q13 chromosomal region are involved in an
advanced prostate cancer xenograft. Cancer Res. 62:6803–6807.
2002.PubMed/NCBI
|
|
10
|
Huang W, Li N, Hu J and Wang L: Inhibitory
effect of RNA-mediated knockdown of zinc finger protein 91
pseudogene on pancreatic cancer cell growth and invasion. Oncol
Lett. 12:1343–1348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jen J and Wang YC: ZNF proteins in cancer
progression. J Biomed Sci. 23:532016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Liu G, Wu S, Jiang F, Xie J and
Wang Y: Zinc finger E-box-binding homeobox 1: Its clinical
significance and functional role in human thyroid cancer. Onco
Targets Ther. 9:1303–1310. 2016.PubMed/NCBI
|
|
13
|
Gaykalova DA, Vatapalli R, Wei Y, Tsai HL,
Wang H, Zhang C, Hennessey PT, Guo T, Tan M, Li R, et al: Outlier
analysis defines zinc finger gene family DNA methylation in tumors
and saliva of head and neck cancer patients. PLoS One.
10:e01421482015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hao YJ, Li Y, Fan LQ, Zhao Q, Tan BB, Jiao
ZK, Zhao XF, Zhang ZD and Wang D: Role of RNA-interference induced
zinc finger protein 139 suppression in gastric cancer cell
sensitivity to chemotherapeutic agents. Oncol Lett. 10:1333–1338.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang J and Liu LY: ZNF protein X-linked
is overexpressed in colorectal cancer and is associated with poor
prognosis. Oncol Lett. 10:810–814. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang G, Ma F, Zhong M, Fang L, Peng Y, Xin
X, Zhong J, Yuan F, Gu H, Zhu W and Zhang Y: ZNF703 acts as an
oncogene that promotes progression in gastric cancer. Oncol Rep.
31:1877–1882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Hamilton SR, Sood A, Kuwai T,
Ellis L, Sanguino A, Lopez-Berestein G and Boyd DD: The previously
undescribed ZKSCAN3 (ZNF306) is a novel ‘driver’ of colorectal
cancer progression. Cancer Res. 68:4321–4330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu R, Peng G, Dai H, Breuer EK,
Stemke-Hale K, Li K, Gonzalez-Angulo AM, Mills GB and Lin SY:
ZNF668 functions as a tumor suppressor by regulating p53 stability
and function in breast cancer. Cancer Res. 71:6524–6534. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Wang Y, Fan X, Mo X, Wang Z, Li Y,
Yin Z, Deng Y, Luo N, Zhu C, et al: ZNF307, a novel zinc finger
gene suppresses p53 and p21 pathway. Biochem Biophys Res Commun.
363:895–900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao S, Hsieh CL, Zhou J and Shemshedini L:
Zinc finger 280B regulates sGCα1 and p53 in prostate cancer cells.
PLoS One. 8:e787662013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y and Mou L: A risk score system to
preoperatively predict TNM stages in gastric cancer. Am J Clin
Oncol. 34:130–134. 2011.PubMed/NCBI
|
|
22
|
Gunn SR, Bolla AR, Barron LL, Gorre ME,
Mohammed MS, Bahler DW, Mellink CH, van Oers MH, Keating MJ,
Ferrajoli A, et al: Array CGH analysis of chronic lymphocytic
leukemia reveals frequent cryptic monoallelic and biallelic
deletions of chromosome 22q11 that include the PRAME gene. Leuk
Res. 33:1276–1281. 2009. View Article : Google Scholar : PubMed/NCBI
|
